Now a Virtual Experience: 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference

Vision for Biomanufacturing:  Today's Challenges and Tomorrow's Therapies

We continue to monitor the unfolding global impact of COVID-19, and as the world evolves, so do we. We are transforming this event to be fully digital: The 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference.  

You will still: 

  • Hear compelling and informative presentations from global experts representing regulatory, industry, and academia 
  • Refine your own expertise and gain new insights into critical trends in the bio sector, including cell and gene therapy, monoclonal antibodies, oligonucleotides, and personalized medicines. 
  • Explore the case studies in process development and equipment design for profitable and sustainable manufacturing  
  • Learn about innovations in facility design and operations, and strategies for collaboration between manufacturers and regulators 
  • See how you can implement best practices used by CDMOs in non-traditional biopharma processes 
  • Understand the supply chain risks and challenges associated with the production of personalized medicines 

It's our priority to make this the best and most informative ISPE Biopharmaceutical Manufacturing Conference to date, and we remain excited to host you in June. We will update the event page in the coming weeks with additional information.  

Who Should Attend

  • Emerging Technologies Scientists and Professionals 
  • Bio Site Directors and above 
  • Operations managers 
  • Manufacturing, Quality Control and Quality Assurance heads 
  • Procurement professionals 
  • Engineering and Facility management heads 
  • Contract Manufacturing interface heads 
  • Key supply chain interfaces 
  • Process sciences, process development heads 
  • Global Regulatory Authorities involved in BLA, PAI, New Technologies 
  • Construction services, engineering services 
  • Suppliers (resins, media, etc.) 

All levels of experience will benefit from the presentations and opportunities for engagement to continue to shape the direction of the pharmaceutical industry

Program Committee 

Joseph C. Famulare
Vice President, Global Quality Compliance and External Relations
Genentech, Inc.
Vivianne J. Arencibia
Independent Consultant
Arencibia Quality Compliance Associates
Board Ambassador
Antonio R. Moreira, PhD
Vice Provost, Academic Affairs
University of Maryland, Baltimore County
Andre L. Walker, CPIP
Walker BioPharm Consulting
Stephen C. Mahoney, JD
Senior Director, Global Quality & Compliance
Darren M. Dasburg
Bio Executive
Self Employed
Christine M. V. Moore, PhD
Global Head and Executive Director, GRACS CMC Policy
Merck & Co.
David Doleski
Compliance Head for Biologics Quality Operations
Robert Dream, PE, CPIP
HDR Company LLC
Eric D. Felz
Associate Director Validation
Takeda Pharmaceutical Company Limited